HALO got screwed by the FDA, but the recent EMA approval should open the door for their partnered programs with big pharma. Its got proven technology but gets no respect from investors. Traders have controlled the stock price & made a fortune playing the swings. Sell the pop & buying the dip.
If you just consider one drug, PEGPH20 then that alone is worth the current market cap. They recently reported a significant improvement in a Phase Ib trial for pancreatic cancer. This drug could be part of first line treatment for pancreatic as well as other cancers. Several Phase II trials have started & if they can report positive results (may take a few years) then I doubt they would even have to conduct a Phase III.
HALO could see another partnered drug approval this month in the EMA & they will report some phase II data this month on cellulite treatment. These could be significant catalysts.
I've sort of stayed away from their message board recently since the swing traders are trying to scare retail. I'm overweight the stock. Big pharma should make a play on the company, but I doubt they'd be interested.